In her paperwork, Ms. DeVos said her stake in Theranos was valued at more than $1 million.
Theranos has drawn scrutiny from CMS and the FDA. The company has been sued multiple times over faulty blood tests, and federal prosecutors launched an investigation into the company in 2016 over allegations it misled investors by misrepresenting the readiness of its technologies and operations.
Ms. DeVos reported income from her Theranos holdings at less than $201.
More articles on healthcare finance:
5 latest hospital bankruptcies
Northwestern Memorial HealthCare’s operating income jumps 87%
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.